<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Anesth Essays Res</journal-id><journal-id journal-id-type="iso-abbrev">Anesth Essays Res</journal-id><journal-id journal-id-type="publisher-id">AER</journal-id><journal-title-group><journal-title>Anesthesia, Essays and Researches</journal-title></journal-title-group><issn pub-type="ppub">0259-1162</issn><issn pub-type="epub">2229-7685</issn><publisher><publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28298754</article-id><article-id pub-id-type="pmc">5341634</article-id><article-id pub-id-type="publisher-id">AER-11-40</article-id><article-id pub-id-type="doi">10.4103/0259-1162.200225</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Perineural Nalbuphine in Ambulatory Upper Limb Surgery: A Comparison of Effects of Levobupivacaine with and without Nalbuphine as Adjuvant in Supraclavicular Brachial Plexus Block – A Prospective, Double-blinded, Randomized Controlled Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Das</surname><given-names>Anjan</given-names></name><xref ref-type="aff" rid="aff1"></xref><xref ref-type="corresp" rid="cor1"></xref></contrib><contrib contrib-type="author"><name><surname>RoyBasunia</surname><given-names>Sandip</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Mukherjee</surname><given-names>Anindya</given-names></name><xref ref-type="aff" rid="aff3">2</xref></contrib><contrib contrib-type="author"><name><surname>Biswas</surname><given-names>Hirak</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Biswas</surname><given-names>Rajasree</given-names></name><xref ref-type="aff" rid="aff4">3</xref></contrib><contrib contrib-type="author"><name><surname>Mitra</surname><given-names>Tapobrata</given-names></name><xref ref-type="aff" rid="aff5">4</xref></contrib><contrib contrib-type="author"><name><surname>Chattopadhyay</surname><given-names>Surajit</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Mandal</surname><given-names>Subrata Kumar</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib></contrib-group><aff id="aff1">Department of Anaesthesiology, College of Medicine and Sagore Dutta Hospital, Kolkata, West Bengal, India</aff><aff id="aff2"><label>1</label>Department of Anaesthesiology, Midnapore Medical College and Hospital, Midnapore, West Bengal, India</aff><aff id="aff3"><label>2</label>Department of Anaesthesiology, N.R.S. Medical College and Hospital, Kolkata, West Bengal, India</aff><aff id="aff4"><label>3</label>Department of Anaesthesiology, Institute of Post Graduate Medical Education and Research, Kolkata, West Bengal, India</aff><aff id="aff5"><label>4</label>Department of Anaesthesiology, Murshidabad Medical College, Berhampore, West Bengal, India</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Anjan Das, 174, Gorakshabashi Road, Royal Plaza Apartment (4<sup>th</sup> Floor, Flat No. 1), Nagerbazar, Kolkata - 700 028, West Bengal, India. E-mail: <email xlink:href="anjan2k8@yahoo.com">anjan2k8@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jan-Mar</season><year>2017</year></pub-date><volume>11</volume><issue>1</issue><fpage>40</fpage><lpage>46</lpage><permissions><copyright-statement>Copyright: © 2017 Anesthesia: Essays and Researches</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title><offsets xml_i="4427" xml_f="4447" txt_i="11" txt_f="31">Background and Aims:</offsets></title><p><offsets xml_i="4458" xml_f="4764" txt_i="32" txt_f="338">Various opioid additives have been trialed to prolong brachial plexus block. We evaluated the effect of adding nalbuphine hydrochloride to levobupivacaine for supraclavicular brachial plexus blockade. The primary end-points were the onset and duration of sensory and motor blocks and duration of analgesia.</offsets></p></sec><sec id="st2"><title><offsets xml_i="4795" xml_f="4817" txt_i="340" txt_f="362">Materials and Methods:</offsets></title><p><offsets xml_i="4828" xml_f="5067" txt_i="363" txt_f="602">Seventy-eight patients (aged 25–45 years) posted for ambulatory forearm and hand surgery under supraclavicular brachial plexus block were divided into two equal groups (Groups LN and LC) in a randomized, double-blind fashion. In Group LN (</offsets><italic><offsets xml_i="5075" xml_f="5076" txt_i="602" txt_f="603">n</offsets></italic><offsets xml_i="5085" xml_f="5201" txt_i="603" txt_f="719"> = 39), 30 ml 0.5% levobupivacaine + 10 mg (diluted in 2 ml 0.9% saline) nalbuphine hydrochloride, and in Group LC (</offsets><italic><offsets xml_i="5209" xml_f="5210" txt_i="719" txt_f="720">n</offsets></italic><offsets xml_i="5219" xml_f="5537" txt_i="720" txt_f="1038"> = 39), 30 ml 0.5% levobupivacaine + 2 ml normal saline (0.9%) were administered in supraclavicular block. Sensory and motor block onset times and block durations, time to first analgesic use, total analgesic need, postoperative visual analog scale (VAS), hemodynamics, and side effects were recorded for each patient.</offsets></p></sec><sec id="st3"><title><offsets xml_i="5568" xml_f="5576" txt_i="1040" txt_f="1048">Results:</offsets></title><p><offsets xml_i="5587" xml_f="5826" txt_i="1049" txt_f="1288">Although with similar demographic profile and block (sensory and motor) onset time, sensory and motor block duration and time to first analgesic use were significantly longer and the total need for rescue analgesics was lower in Group LN (</offsets><italic><offsets xml_i="5834" xml_f="5835" txt_i="1288" txt_f="1289">P</offsets></italic><offsets xml_i="5844" xml_f="5940" txt_i="1289" txt_f="1382"> &lt; 0.05) than Group LC. Postoperative VAS value at 24 h was significantly lower in Group LN (</offsets><italic><offsets xml_i="5948" xml_f="5949" txt_i="1382" txt_f="1383">P</offsets></italic><offsets xml_i="5958" xml_f="6107" txt_i="1383" txt_f="1529"> &lt; 0.05). Intraoperative hemodynamics was comparable between two groups, and no any appreciable side effect was noted throughout the study period.</offsets></p></sec><sec id="st4"><title><offsets xml_i="6138" xml_f="6149" txt_i="1531" txt_f="1542">Conclusion:</offsets></title><p><offsets xml_i="6160" xml_f="6393" txt_i="1543" txt_f="1776">It can be concluded that adding nalbuphine hydrochloride to supraclavicular brachial plexus block increases the sensory and motor block duration and time to first analgesic use, and decreases total analgesic use with no side effects.</offsets></p></sec></abstract><kwd-group><kwd>Levobupivacaine</kwd><kwd>nalbuphine hydrochloride</kwd><kwd>supraclavicular brachial plexus block</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title><offsets xml_i="6616" xml_f="6617" txt_i="1785" txt_f="1786">I</offsets><sc><offsets xml_i="6621" xml_f="6632" txt_i="1786" txt_f="1797">NTRODUCTION</offsets></sc></title><p><offsets xml_i="6648" xml_f="6763" txt_i="1798" txt_f="1913">Pain frequently hampers the implementation of ambulatory surgery in spite of so many analgesic drugs and regimens.[</offsets><xref rid="ref1" ref-type="bibr"><offsets xml_i="6796" xml_f="6797" txt_i="1913" txt_f="1914">1</offsets></xref><offsets xml_i="6804" xml_f="6984" txt_i="1914" txt_f="2094">] Postoperative pain has a negative impact on patient's early mobilization and discharge as well as it causes unanticipated hospital admission, particularly in a day care setting.[</offsets><xref rid="ref2" ref-type="bibr"><offsets xml_i="7017" xml_f="7018" txt_i="2094" txt_f="2095">2</offsets></xref><offsets xml_i="7025" xml_f="7026" txt_i="2095" txt_f="2096">]</offsets></p><p><offsets xml_i="7033" xml_f="7367" txt_i="2097" txt_f="2431">Upper limb surgeries below mid arm are mostly performed under peripheral blocks such as the brachial plexus block. Peripheral nerve blocks provide intraoperative anesthesia as well as it extends analgesia in the postoperative period without major systemic side effects by minimizing stress response and using minimal analgesic drugs.[</offsets><xref rid="ref3" ref-type="bibr"><offsets xml_i="7400" xml_f="7401" txt_i="2431" txt_f="2432">3</offsets></xref><offsets xml_i="7408" xml_f="7409" txt_i="2432" txt_f="2433">]</offsets></p><p><offsets xml_i="7416" xml_f="7544" txt_i="2434" txt_f="2562">Levobupivacaine, the S-enantiomer of bupivacaine, is a comparatively newer local anesthetic agent acting on voltage-dependent Na</offsets><sup><offsets xml_i="7549" xml_f="7550" txt_i="2562" txt_f="2563">+</offsets></sup><offsets xml_i="7556" xml_f="7751" txt_i="2563" txt_f="2758"> channels, introduced into clinical practice, and it also possesses less cardiac and neural toxicities. Levobupivacaine has been shown to be safe and effective for epidural and spinal anesthesia[</offsets><xref rid="ref4" ref-type="bibr"><offsets xml_i="7784" xml_f="7785" txt_i="2758" txt_f="2759">4</offsets></xref><offsets xml_i="7792" xml_f="7831" txt_i="2759" txt_f="2798">] and blockade of the brachial plexus.[</offsets><xref rid="ref4" ref-type="bibr"><offsets xml_i="7864" xml_f="7865" txt_i="2798" txt_f="2799">4</offsets></xref><xref rid="ref5" ref-type="bibr"><offsets xml_i="7905" xml_f="7906" txt_i="2799" txt_f="2800">5</offsets></xref><xref rid="ref6" ref-type="bibr"><offsets xml_i="7946" xml_f="7947" txt_i="2800" txt_f="2801">6</offsets></xref><offsets xml_i="7954" xml_f="7955" txt_i="2801" txt_f="2802">]</offsets></p><p><offsets xml_i="7962" xml_f="8160" txt_i="2803" txt_f="3001">Local anesthetics alone for supraclavicular brachial plexus block provide good operative conditions but have a shorter duration of postoperative analgesia. Hence, various adjuvants such as opioids,[</offsets><xref rid="ref7" ref-type="bibr"><offsets xml_i="8193" xml_f="8194" txt_i="3001" txt_f="3002">7</offsets></xref><offsets xml_i="8201" xml_f="8214" txt_i="3002" txt_f="3015">] clonidine,[</offsets><xref rid="ref8" ref-type="bibr"><offsets xml_i="8247" xml_f="8248" txt_i="3015" txt_f="3016">8</offsets></xref><offsets xml_i="8255" xml_f="8285" txt_i="3016" txt_f="3046">] neostigmine, dexamethasone,[</offsets><xref rid="ref9" ref-type="bibr"><offsets xml_i="8318" xml_f="8319" txt_i="3046" txt_f="3047">9</offsets></xref><offsets xml_i="8326" xml_f="8339" txt_i="3047" txt_f="3060">] midazolam,[</offsets><xref rid="ref10" ref-type="bibr"><offsets xml_i="8373" xml_f="8375" txt_i="3060" txt_f="3062">10</offsets></xref><offsets xml_i="8382" xml_f="8398" txt_i="3062" txt_f="3078">] and magnesium[</offsets><xref rid="ref11" ref-type="bibr"><offsets xml_i="8432" xml_f="8434" txt_i="3078" txt_f="3080">11</offsets></xref><offsets xml_i="8441" xml_f="8628" txt_i="3080" txt_f="3267">] have been added to local anesthetics in brachial plexus block to achieve quick, dense, and prolonged block; however, the results are either inconclusive or associated with side effects.</offsets></p><p><offsets xml_i="8635" xml_f="8880" txt_i="3268" txt_f="3513">Nalbuphine, derivative of 14-hydroxymorphine, is an agonist-antagonist opioid acting on µ (mu) receptors as antagonist and κ (kappa) receptors as agonist with an analgesic potency equal to morphine and its antagonistic potency is approximately ¼</offsets><sup><offsets xml_i="8885" xml_f="8887" txt_i="3513" txt_f="3515">th</offsets></sup><offsets xml_i="8893" xml_f="8915" txt_i="3515" txt_f="3537"> of that of naloxone.[</offsets><xref rid="ref12" ref-type="bibr"><offsets xml_i="8949" xml_f="8951" txt_i="3537" txt_f="3539">12</offsets></xref><offsets xml_i="8958" xml_f="9033" txt_i="3539" txt_f="3614">] Unlike morphine, it exhibits a ceiling effect on respiratory depression.[</offsets><xref rid="ref13" ref-type="bibr"><offsets xml_i="9067" xml_f="9069" txt_i="3614" txt_f="3616">13</offsets></xref><offsets xml_i="9076" xml_f="9219" txt_i="3616" txt_f="3759">] Nalbuphine has the potential to maintain or even enhance µ-opioid-based analgesia while simultaneously mitigating the µ-opioid side effects.[</offsets><xref rid="ref14" ref-type="bibr"><offsets xml_i="9253" xml_f="9255" txt_i="3759" txt_f="3761">14</offsets></xref><offsets xml_i="9262" xml_f="9434" txt_i="3761" txt_f="3933">] Nalbuphine has the onset of action between 2 and 3 min, duration of action of 3–6 h with cardiovascular stability, and minimal side effects in the dose of 0.2–0.4 mg/kg.[</offsets><xref rid="ref13" ref-type="bibr"><offsets xml_i="9468" xml_f="9470" txt_i="3933" txt_f="3935">13</offsets></xref><xref rid="ref15" ref-type="bibr"><offsets xml_i="9511" xml_f="9513" txt_i="3935" txt_f="3937">15</offsets></xref><offsets xml_i="9520" xml_f="9658" txt_i="3937" txt_f="4075">] Because of its safety profile, nalbuphine can be used for pain management in children with burns, neoplastic or hematological diseases.[</offsets><xref rid="ref16" ref-type="bibr"><offsets xml_i="9692" xml_f="9694" txt_i="4075" txt_f="4077">16</offsets></xref><offsets xml_i="9701" xml_f="9870" txt_i="4077" txt_f="4246">] Freedom from controlled drug act regulations and improved analgesia with nalbuphine render it more satisfactory for day care surgery than other commonly used opioids.[</offsets><xref rid="ref17" ref-type="bibr"><offsets xml_i="9904" xml_f="9906" txt_i="4246" txt_f="4248">17</offsets></xref><xref rid="ref18" ref-type="bibr"><offsets xml_i="9947" xml_f="9949" txt_i="4248" txt_f="4250">18</offsets></xref><offsets xml_i="9956" xml_f="10125" txt_i="4250" txt_f="4419">] Despite its known benefits for pain control, nalbuphine has never been studied extensively for its effects as an adjuvant to anesthetics during brachial plexus blocks.</offsets></p><p><offsets xml_i="10132" xml_f="10454" txt_i="4420" txt_f="4742">Our current study was designed to test the hypothesis that nalbuphine when added as an adjuvant to levobupivacaine in supraclavicular brachial plexus block enhanced the onset, duration of sensory and motor blocks, duration of analgesia, and quality of block for the patients undergoing ambulatory forearm and hand surgery.</offsets></p></sec><sec sec-type="materials|methods" id="sec1-2"><title><offsets xml_i="10517" xml_f="10518" txt_i="4744" txt_f="4745">M</offsets><sc><offsets xml_i="10522" xml_f="10534" txt_i="4745" txt_f="4757">ATERIALS AND</offsets></sc><offsets xml_i="10539" xml_f="10541" txt_i="4757" txt_f="4759"> M</offsets><sc><offsets xml_i="10545" xml_f="10551" txt_i="4759" txt_f="4765">ETHODS</offsets></sc></title><p><offsets xml_i="10567" xml_f="10743" txt_i="4766" txt_f="4942">After obtaining permission from the Institutional Ethics Committee, written informed consent was taken. Totally, 78 adult patients were randomly allocated to two equal groups (</offsets><italic><offsets xml_i="10751" xml_f="10752" txt_i="4942" txt_f="4943">n</offsets></italic><offsets xml_i="10761" xml_f="11326" txt_i="4943" txt_f="5508"> = 39 in each group) using computer-generated random number list. The American Society of Anesthesiologists (ASA) physical status I and II aged between 25 and 45 years of both sexes undergoing ambulatory elective orthopedic surgeries of forearm and hand under supraclavicular brachial plexus block were enrolled in the study. Patients in Group LN received 30 ml 0.5% levobupivacaine + 10 mg (diluted in 2 ml 0.9% saline) nalbuphine hydrochloride for supraclavicular block. Group LC received 30 ml 0.5% levobupivacaine + 2 ml normal saline (0.9%) for the same block.</offsets></p><sec id="sec2-1"><title><offsets xml_i="11354" xml_f="11372" txt_i="5509" txt_f="5527">Exclusion criteria</offsets></title><p><offsets xml_i="11383" xml_f="11816" txt_i="5528" txt_f="5961">Patient refusal, any known hypersensitivity or contraindication to levobupivacaine, nalbuphine hydrochloride, pregnancy, lactating mothers, hepatic, renal or cardiopulmonary abnormality, alcoholism, diabetes, long-term analgesic therapy, bleeding diathesis, and local skin site infections were excluded from the study. Patients having a history of significant neurological, psychiatric, or neuromuscular disorders were also excluded.</offsets></p><p><offsets xml_i="11823" xml_f="12425" txt_i="5962" txt_f="6564">In preoperative assessment, the patients were enquired about any history of drug allergy, previous operations, or prolonged drug treatment. General examination, systemic examinations, and assessment of the airway were done. Preoperative fasting of minimum 6 h was ensured before the operation. All patients received premedication of tablet diazepam 10 mg orally the night before surgery as per preanesthetic check-up direction to allay anxiety, apprehension, and for sound sleep. The patients also received tablet ranitidine 150 mg in the previous night and the morning of operation with sips of water.</offsets></p><p><offsets xml_i="12432" xml_f="13164" txt_i="6565" txt_f="7297">All patients were clinically examined in the preoperative period and routine investigations were checked, and at the same time, whole procedure was explained. Ten centimeters visual analog scale (VAS) (0 – no pain and 10 – worst pain imaginable) was also explained during preoperative visit. On entering the patient in the operating room, standard intraoperative monitors such as electrocardiogram, pulse oximeter, and noninvasive blood pressure were attached and baseline parameter was recorded. Philips IntelliVue MP20 monitor was used for this purpose. Intravenous infusion of Ringer's lactate was started and oxygen was given at 2 L/min via nasal prong. All patients received injection midazolam 0.04 mg/kg before the procedure.</offsets></p><p><offsets xml_i="13171" xml_f="13538" txt_i="7298" txt_f="7665">After proper explanation of technique, positioning interscalene groove was indentified, where a mark was made approximately 1.5–2.0 cm posterior to the mid-clavicle point. The stimulation frequency was set at 1 Hz, and the intensity of the stimulating current was initially set to deliver 2 mA and was then gradually decreased. The 22-gauge 5 cm, insulated, Stimuplex</offsets><sup><offsets xml_i="13543" xml_f="13544" txt_i="7665" txt_f="7666">®</offsets></sup><offsets xml_i="13550" xml_f="14131" txt_i="7666" txt_f="8244"> A needle was used. The position of the needle was considered to be acceptable when an output current &lt;0.5 mA still elicited a slight distal motor response in forearm and hand. On negative aspiration for blood, a total volume of 32 ml solution was injected slowly as per allotment of the group and drug. The anesthesiologist performing supraclavicular block was unaware of the constituent of the drug and allotment of the group, and similarly, resident doctors keeping records of different parameters were also unaware of group allotment. Thus, blinding was properly maintained.</offsets></p><p><offsets xml_i="14138" xml_f="14569" txt_i="8245" txt_f="8676">Sensory and motor blockades were assessed every 2 min after the completion of injection till 30 min and then every 30 min after the end of surgery till first 10 h, thereafter hourly until the block had completely worn off. Sensory blockade of each nerve was assessed by pinprick. Onset time of motor blockade was defined as the time interval between the end of local anesthetic injection and paresis in all the nerve distributions.</offsets></p><p><offsets xml_i="14576" xml_f="15139" txt_i="8677" txt_f="9240">The duration of sensory block was defined as the time interval between the onset of sensory block and the first postoperative pain. The duration of motor block was defined as the time interval between the onset of motor block and complete recovery of motor functions. After 30 min, if the block was considered to be adequate, surgery commenced. Injection diclofenac sodium (rescue analgesic) 75 mg was given intramuscularly when VAS ≥3 cm. The number of injection diclofenac sodium given to each patient during first 24 h of the postoperative period was recorded.</offsets></p></sec><sec id="sec2-2"><title><offsets xml_i="15173" xml_f="15193" txt_i="9242" txt_f="9262">Statistical analysis</offsets></title><p><offsets xml_i="15204" xml_f="15559" txt_i="9263" txt_f="9618">After a crossover pilot study of ten patients, we estimated the first rescue analgesic requirement time in each group was 510 min. The sample size was estimated using first rescue analgesic requirement between two groups as the main primary variable. The average duration in each group was 510 min and to detect a difference of 10% (i.e., 51 min), at the </offsets><italic><offsets xml_i="15567" xml_f="15568" txt_i="9618" txt_f="9619">P</offsets></italic><offsets xml_i="15577" xml_f="16092" txt_i="9619" txt_f="10131"> &lt; 0.05 level, with a probability of detecting a difference of 80% (1−beta = 0.80). On the basis of previous study assuming within group standard deviation of 90 min, we need to study at least 36 patients per group to be able to reject the null hypothesis that the population means of the groups are equal with probability (power) 0.80. We had taken 39 patients in each group for this prospective study. Raw data were entered into Microsoft Excel spreadsheet and analyzed using standard statistical software SPSS</offsets><sup><offsets xml_i="16097" xml_f="16098" txt_i="10131" txt_f="10132">®</offsets></sup><offsets xml_i="16104" xml_f="16351" txt_i="10132" txt_f="10379"> Statistical Package for the Social Sciences version 18.0 (SPSS Inc., Chicago, IL, USA). Categorical variables were analyzed using the Pearson's Chi-square test. Normally distributed continuous variables were analyzed using the independent sample </offsets><italic><offsets xml_i="16359" xml_f="16360" txt_i="10379" txt_f="10380">t</offsets></italic><offsets xml_i="16369" xml_f="16379" txt_i="10380" txt_f="10390">-test and </offsets><italic><offsets xml_i="16387" xml_f="16388" txt_i="10390" txt_f="10391">P</offsets></italic><offsets xml_i="16397" xml_f="16449" txt_i="10391" txt_f="10440"> &lt; 0.05 was considered statistically significant.</offsets></p></sec></sec><sec id="sec1-3"><title><offsets xml_i="16489" xml_f="16490" txt_i="10443" txt_f="10444">R</offsets><sc><offsets xml_i="16494" xml_f="16504" txt_i="10444" txt_f="10454">ESULTS AND</offsets></sc><offsets xml_i="16509" xml_f="16511" txt_i="10454" txt_f="10456"> A</offsets><sc><offsets xml_i="16515" xml_f="16522" txt_i="10456" txt_f="10463">NALYSIS</offsets></sc></title><p><offsets xml_i="16538" xml_f="16774" txt_i="10464" txt_f="10700">We recruited 78 subjects per group, more than the calculated sample size. There were no dropouts. Thirty-nine patients in the nalbuphine group (LN) and 39 in the normal saline control group (LC) were eligible for effectiveness analysis.</offsets></p><p><offsets xml_i="16781" xml_f="16924" txt_i="10701" txt_f="10844">The age, body weight, sex distribution, ASA status, and duration of surgery and tourniquet time in the two groups were found to be comparable [</offsets><xref ref-type="table" rid="T1"><offsets xml_i="16956" xml_f="16963" txt_i="10844" txt_f="10851">Table 1</offsets></xref><offsets xml_i="16970" xml_f="17083" txt_i="10851" txt_f="10964">]. Indications for different upper limb orthopedic surgeries were also similar and had no clinical significance (</offsets><italic><offsets xml_i="17091" xml_f="17092" txt_i="10964" txt_f="10965">P</offsets></italic><offsets xml_i="17101" xml_f="17114" txt_i="10965" txt_f="10975"> &gt; 0.05) [</offsets><xref ref-type="table" rid="T2"><offsets xml_i="17146" xml_f="17153" txt_i="10975" txt_f="10982">Table 2</offsets></xref><offsets xml_i="17160" xml_f="17255" txt_i="10982" txt_f="11077">]. The onset of both sensory and motor blocks was statistically comparable between two groups [</offsets><xref ref-type="table" rid="T3"><offsets xml_i="17287" xml_f="17294" txt_i="11077" txt_f="11084">Table 3</offsets></xref><offsets xml_i="17301" xml_f="17337" txt_i="11084" txt_f="11120">] and was clinically insignificant (</offsets><italic><offsets xml_i="17345" xml_f="17346" txt_i="11120" txt_f="11121">P</offsets></italic><offsets xml_i="17355" xml_f="17376" txt_i="11121" txt_f="11139"> &gt; 0.05). Whereas </offsets><xref ref-type="table" rid="T4"><offsets xml_i="17408" xml_f="17415" txt_i="11139" txt_f="11146">Table 4</offsets></xref><offsets xml_i="17422" xml_f="17427" txt_i="11146" txt_f="11151"> and </offsets><xref ref-type="fig" rid="F1"><offsets xml_i="17457" xml_f="17465" txt_i="11151" txt_f="11159">Figure 1</offsets></xref><offsets xml_i="17472" xml_f="17604" txt_i="11159" txt_f="11291"> show that sensory and motor block durations were both clinically and statistically greater in the group receiving nalbuphine (LN) (</offsets><italic><offsets xml_i="17612" xml_f="17613" txt_i="11291" txt_f="11292">P</offsets></italic><offsets xml_i="17622" xml_f="17648" txt_i="11292" txt_f="11315"> &lt; 0.05) than Group LC.</offsets></p><table-wrap id="T1" position="float"><label><offsets xml_i="17696" xml_f="17703" txt_i="11316" txt_f="11323">Table 1</offsets></label><caption><p><offsets xml_i="17723" xml_f="17782" txt_i="11323" txt_f="11382">Comparison of demographic data between the two study groups</offsets></p></caption><graphic xlink:href="AER-11-40-g001"></graphic></table-wrap><table-wrap id="T2" position="float"><label><offsets xml_i="17900" xml_f="17907" txt_i="11383" txt_f="11390">Table 2</offsets></label><caption><p><offsets xml_i="17927" xml_f="17977" txt_i="11390" txt_f="11440">Indications of upper limb surgeries for two groups</offsets></p></caption><graphic xlink:href="AER-11-40-g002"></graphic></table-wrap><table-wrap id="T3" position="float"><label><offsets xml_i="18095" xml_f="18102" txt_i="11441" txt_f="11448">Table 3</offsets></label><caption><p><offsets xml_i="18122" xml_f="18161" txt_i="11448" txt_f="11487">Onset time for sensory and motor blocks</offsets></p></caption><graphic xlink:href="AER-11-40-g003"></graphic></table-wrap><table-wrap id="T4" position="float"><label><offsets xml_i="18279" xml_f="18286" txt_i="11488" txt_f="11495">Table 4</offsets></label><caption><p><offsets xml_i="18306" xml_f="18342" txt_i="11495" txt_f="11531">Duration of sensory and motor blocks</offsets></p></caption><graphic xlink:href="AER-11-40-g004"></graphic></table-wrap><fig id="F1" position="float"><label><offsets xml_i="18453" xml_f="18461" txt_i="11532" txt_f="11540">Figure 1</offsets></label><caption><p><offsets xml_i="18481" xml_f="18518" txt_i="11540" txt_f="11577">Duration of sensory and motor blocks.</offsets></p></caption><graphic xlink:href="AER-11-40-g005"></graphic></fig><p><offsets xml_i="18588" xml_f="18874" txt_i="11578" txt_f="11864">The mean time from block placement to the first request for pain medication, i.e., the duration of analgesia was 531.45 min in the nalbuphine group but 501.02 min in the control normal saline group. This difference (about 30.43 min) was statistically as well as clinically significant (</offsets><italic><offsets xml_i="18882" xml_f="18883" txt_i="11864" txt_f="11865">P</offsets></italic><offsets xml_i="18892" xml_f="18905" txt_i="11865" txt_f="11875"> &lt; 0.05) [</offsets><xref ref-type="table" rid="T5"><offsets xml_i="18937" xml_f="18944" txt_i="11875" txt_f="11882">Table 5</offsets></xref><offsets xml_i="18951" xml_f="18956" txt_i="11882" txt_f="11887"> and </offsets><xref ref-type="fig" rid="F2"><offsets xml_i="18986" xml_f="18994" txt_i="11887" txt_f="11895">Figure 2</offsets></xref><offsets xml_i="19001" xml_f="19003" txt_i="11895" txt_f="11897">].</offsets></p><table-wrap id="T5" position="float"><label><offsets xml_i="19051" xml_f="19058" txt_i="11898" txt_f="11905">Table 5</offsets></label><caption><p><offsets xml_i="19078" xml_f="19190" txt_i="11905" txt_f="12017">Rescue analgesic requirement in postoperative period (time and no of intramuscular diclofenac sodium injections)</offsets></p></caption><graphic xlink:href="AER-11-40-g006"></graphic></table-wrap><fig id="F2" position="float"><label><offsets xml_i="19301" xml_f="19309" txt_i="12018" txt_f="12026">Figure 2</offsets></label><caption><p><offsets xml_i="19329" xml_f="19398" txt_i="12026" txt_f="12095">Time of first intramuscular diclofenac injection as rescue analgesic.</offsets></p></caption><graphic xlink:href="AER-11-40-g007"></graphic></fig><p><xref ref-type="table" rid="T5"><offsets xml_i="19500" xml_f="19507" txt_i="12096" txt_f="12103">Table 5</offsets></xref><offsets xml_i="19514" xml_f="19752" txt_i="12103" txt_f="12341"> shows that Group LN required less amount of diclofenac sodium injection as rescue analgesics than patients in Group LC (control saline group) in first 24 h of postoperative period, and the difference is statistically highly significant (</offsets><italic><offsets xml_i="19760" xml_f="19761" txt_i="12341" txt_f="12342">P</offsets></italic><offsets xml_i="19770" xml_f="19782" txt_i="12342" txt_f="12351"> &lt; 0.05).</offsets></p><p><xref ref-type="table" rid="T6"><offsets xml_i="19821" xml_f="19828" txt_i="12352" txt_f="12359">Table 6</offsets></xref><offsets xml_i="19835" xml_f="20011" txt_i="12359" txt_f="12535"> shows the side effects encountered throughout our study which indicates that Group LN suffered from slightly more nausea and sedation, but it was statistically insignificant (</offsets><italic><offsets xml_i="20019" xml_f="20020" txt_i="12535" txt_f="12536">P</offsets></italic><offsets xml_i="20029" xml_f="20069" txt_i="12536" txt_f="12573"> &gt; 0.05) when compared with Group LC.</offsets></p><table-wrap id="T6" position="float"><label><offsets xml_i="20117" xml_f="20124" txt_i="12574" txt_f="12581">Table 6</offsets></label><caption><p><offsets xml_i="20144" xml_f="20170" txt_i="12581" txt_f="12607">Comparison of side effects</offsets></p></caption><graphic xlink:href="AER-11-40-g008"></graphic></table-wrap><p><xref ref-type="fig" rid="F3"><offsets xml_i="20277" xml_f="20285" txt_i="12608" txt_f="12616">Figure 3</offsets></xref><offsets xml_i="20292" xml_f="20487" txt_i="12616" txt_f="12811"> shows that VAS score was of much higher value in Group LN than LC Group. Consort flow diagram shows the patient enrollment, allocation, follow-up, and analysis of all the patients in the study [</offsets><xref ref-type="fig" rid="F4"><offsets xml_i="20517" xml_f="20529" txt_i="12811" txt_f="12823">Flow Chart 1</offsets></xref><offsets xml_i="20536" xml_f="20538" txt_i="12823" txt_f="12825">].</offsets></p><fig id="F3" position="float"><label><offsets xml_i="20579" xml_f="20587" txt_i="12826" txt_f="12834">Figure 3</offsets></label><caption><p><offsets xml_i="20607" xml_f="20677" txt_i="12834" txt_f="12904">Comparison of visual analog scale score between Group LN and Group LC.</offsets></p></caption><graphic xlink:href="AER-11-40-g009"></graphic></fig><fig id="F4" position="float"><label><offsets xml_i="20781" xml_f="20792" txt_i="12905" txt_f="12916">Flowchart 1</offsets></label><caption><p><offsets xml_i="20812" xml_f="20838" txt_i="12916" txt_f="12942">CONSORT 2010 flow diagram.</offsets></p></caption><graphic xlink:href="AER-11-40-g010"></graphic></fig></sec><sec sec-type="discussion" id="sec1-4"><title><offsets xml_i="20957" xml_f="20958" txt_i="12944" txt_f="12945">D</offsets><sc><offsets xml_i="20962" xml_f="20971" txt_i="12945" txt_f="12954">ISCUSSION</offsets></sc></title><p><offsets xml_i="20987" xml_f="21155" txt_i="12955" txt_f="13123">Day care surgery has proven over the years as the best method to reduce the burden on the health-care resources as well as achievement of extreme patient satisfaction.[</offsets><xref rid="ref19" ref-type="bibr"><offsets xml_i="21189" xml_f="21191" txt_i="13123" txt_f="13125">19</offsets></xref><offsets xml_i="21198" xml_f="21508" txt_i="13125" txt_f="13435">] In developing countries, most of the patients avoid bearing expenses of prolonged hospital stay. In the present day scenario, pain is the most common medical cause of delayed recovery and discharge after ambulatory surgery and a frequent cause of unplanned admission and subsequently delayed return to work.[</offsets><xref rid="ref20" ref-type="bibr"><offsets xml_i="21542" xml_f="21544" txt_i="13435" txt_f="13437">20</offsets></xref><xref rid="ref21" ref-type="bibr"><offsets xml_i="21585" xml_f="21587" txt_i="13437" txt_f="13439">21</offsets></xref><offsets xml_i="21594" xml_f="21595" txt_i="13439" txt_f="13440">]</offsets></p><p><offsets xml_i="21602" xml_f="21735" txt_i="13441" txt_f="13574">In supraclavicular blocks, typical features include rapid onset, predictable, and dense anesthesia along with its high success rate.[</offsets><xref rid="ref22" ref-type="bibr"><offsets xml_i="21769" xml_f="21771" txt_i="13574" txt_f="13576">22</offsets></xref><offsets xml_i="21778" xml_f="21914" txt_i="13576" txt_f="13712">] Various adjuvants have been tried along with local anesthetics in brachial plexus block to achieve quick, dense, and prolonged block;[</offsets><xref rid="ref23" ref-type="bibr"><offsets xml_i="21948" xml_f="21950" txt_i="13712" txt_f="13714">23</offsets></xref><offsets xml_i="21957" xml_f="22036" txt_i="13714" txt_f="13793">] however, the results are either inconclusive or associated with side effects.</offsets></p><p><offsets xml_i="22043" xml_f="22130" txt_i="13794" txt_f="13881">Nalbuphine has been used as ambulatory sedative along with propofol for pediatric MRI.[</offsets><xref rid="ref24" ref-type="bibr"><offsets xml_i="22164" xml_f="22166" txt_i="13881" txt_f="13883">24</offsets></xref><offsets xml_i="22173" xml_f="22278" txt_i="13883" txt_f="13988">] Again, the drug has been proven to prevent hemodynamic surges associated with endotracheal intubation.[</offsets><xref rid="ref25" ref-type="bibr"><offsets xml_i="22312" xml_f="22314" txt_i="13988" txt_f="13990">25</offsets></xref><offsets xml_i="22321" xml_f="22444" txt_i="13990" txt_f="14113">] Nalbuphine, like fentanyl, is also popular in producing analgesia during conscious sedation for outpatient oral surgery.[</offsets><xref rid="ref26" ref-type="bibr"><offsets xml_i="22478" xml_f="22480" txt_i="14113" txt_f="14115">26</offsets></xref><offsets xml_i="22487" xml_f="22635" txt_i="14115" txt_f="14263">] The drug is also very effective in subarachnoid as well as epidural route for prolonging sensory block duration and delays analgesic requirement.[</offsets><xref rid="ref27" ref-type="bibr"><offsets xml_i="22669" xml_f="22671" txt_i="14263" txt_f="14265">27</offsets></xref><xref rid="ref28" ref-type="bibr"><offsets xml_i="22712" xml_f="22714" txt_i="14265" txt_f="14267">28</offsets></xref><offsets xml_i="22721" xml_f="22872" txt_i="14267" txt_f="14418">] Success and nontoxicity of the drug in subarachnoid and epidural route ensure the drug can safely be used perineurally in any peripheral nerve block.</offsets></p><p><offsets xml_i="22879" xml_f="23383" txt_i="14419" txt_f="14923">In this prospective, randomized, double-blinded trial, we had compared the effect of nalbuphine hydrochloride (10 mg) diluted in 2 ml normal saline solution and the same volume of normal saline (as control) as an adjuvant to 30 ml 0.50% levobupivacaine in supraclavicular brachial plexus block, on the onset and duration of sensory and motor blocks as well as on the postoperative rescue analgesic (injection diclofenac sodium) requirement for the patients undergoing ambulatory forearm and hand surgery.</offsets></p><p><offsets xml_i="23390" xml_f="23474" txt_i="14924" txt_f="15008">The demographic profile, between two groups, which was statistically insignificant (</offsets><italic><offsets xml_i="23482" xml_f="23483" txt_i="15008" txt_f="15009">P</offsets></italic><offsets xml_i="23492" xml_f="23767" txt_i="15009" txt_f="15281"> &gt; 0.05), of our patients was quite similar with other research investigations and provided us the uniform platform to evenly compare the results obtained. A study on the role of nalbuphine for prolongation and quality of postoperative analgesia was conducted by Chatrath </offsets><italic><offsets xml_i="23775" xml_f="23780" txt_i="15281" txt_f="15286">et al</offsets></italic><offsets xml_i="23789" xml_f="23846" txt_i="15286" txt_f="15343">. in a total of eighty patients yielded similar results.[</offsets><xref rid="ref28" ref-type="bibr"><offsets xml_i="23880" xml_f="23882" txt_i="15343" txt_f="15345">28</offsets></xref><offsets xml_i="23889" xml_f="24023" txt_i="15345" txt_f="15479">] The mean duration of surgery and tourniquet time was almost comparable in both groups with no statistically significant difference [</offsets><xref ref-type="table" rid="T1"><offsets xml_i="24055" xml_f="24062" txt_i="15479" txt_f="15486">Table 1</offsets></xref><offsets xml_i="24069" xml_f="24077" txt_i="15486" txt_f="15494">]. From </offsets><xref ref-type="table" rid="T2"><offsets xml_i="24109" xml_f="24116" txt_i="15494" txt_f="15501">Table 2</offsets></xref><offsets xml_i="24123" xml_f="24256" txt_i="15501" txt_f="15634">, it is quite evident that indications of surgical procedures were almost similar in both groups and had no statistical significance.</offsets></p><p><offsets xml_i="24263" xml_f="24407" txt_i="15635" txt_f="15779">The onset time of sensory block, 15.46 ± 3.44 min, in LN Group versus 16.10 ± 4.08 min in LC Group was quite comparable between the two groups (</offsets><italic><offsets xml_i="24415" xml_f="24416" txt_i="15779" txt_f="15780">P</offsets></italic><offsets xml_i="24425" xml_f="24435" txt_i="15780" txt_f="15790"> = 0.46) [</offsets><xref ref-type="table" rid="T3"><offsets xml_i="24467" xml_f="24474" txt_i="15790" txt_f="15797">Table 3</offsets></xref><offsets xml_i="24481" xml_f="24624" txt_i="15797" txt_f="15940">]. Similarly, onset of motor block (20.34 ± 4.76 min in LN Group vs. 21.86 ± 5.34 min in Group LC) was also comparable between the two groups (</offsets><italic><offsets xml_i="24632" xml_f="24633" txt_i="15940" txt_f="15941">P</offsets></italic><offsets xml_i="24642" xml_f="24659" txt_i="15941" txt_f="15958"> = 0.19). Tiwari </offsets><italic><offsets xml_i="24667" xml_f="24672" txt_i="15958" txt_f="15963">et al</offsets></italic><offsets xml_i="24681" xml_f="24683" txt_i="15963" txt_f="15965">.[</offsets><xref rid="ref27" ref-type="bibr"><offsets xml_i="24717" xml_f="24719" txt_i="15965" txt_f="15967">27</offsets></xref><offsets xml_i="24726" xml_f="24958" txt_i="15967" txt_f="16199">] found that the use of intrathecal nalbuphine and its increased concentration caused a proportional earlier onset of sensory and motor blocks, but it was statistically insignificant. Similar results were also observed by Mukherjee </offsets><italic><offsets xml_i="24966" xml_f="24971" txt_i="16199" txt_f="16204">et al</offsets></italic><offsets xml_i="24980" xml_f="24983" txt_i="16204" txt_f="16207">.,[</offsets><xref rid="ref29" ref-type="bibr"><offsets xml_i="25017" xml_f="25019" txt_i="16207" txt_f="16209">29</offsets></xref><offsets xml_i="25026" xml_f="25185" txt_i="16209" txt_f="16368">] who also found that with increasing dose of nalbuphine, earlier onset of sensory and motor blocks occurs, but these values have no statistical significance (</offsets><italic><offsets xml_i="25193" xml_f="25194" txt_i="16368" txt_f="16369">P</offsets></italic><offsets xml_i="25203" xml_f="25215" txt_i="16369" txt_f="16378"> &gt; 0.05).</offsets></p><p><offsets xml_i="25222" xml_f="25410" txt_i="16379" txt_f="16567">In our study, the duration of sensory block (519.11 ± 38.56 min in Group LN vs. 484.54 ± 41.34 min in Group LC) was significantly longer in the nalbuphine group than in the control group (</offsets><italic><offsets xml_i="25418" xml_f="25419" txt_i="16567" txt_f="16568">P</offsets></italic><offsets xml_i="25428" xml_f="25617" txt_i="16568" txt_f="16757"> = 0.0003). The duration of motor block (484.54 ± 40.44 min in LN Group vs. 455.89 ± 39.43 min in LC Group) was also significantly longer in the nalbuphine group than in the control group (</offsets><italic><offsets xml_i="25625" xml_f="25626" txt_i="16757" txt_f="16758">P</offsets></italic><offsets xml_i="25635" xml_f="25699" txt_i="16758" txt_f="16819"> &lt; 0.0022). These findings were quite similar with Ahluwalia </offsets><italic><offsets xml_i="25707" xml_f="25712" txt_i="16819" txt_f="16824">et al</offsets></italic><offsets xml_i="25721" xml_f="25723" txt_i="16824" txt_f="16826">.[</offsets><xref rid="ref30" ref-type="bibr"><offsets xml_i="25757" xml_f="25759" txt_i="16826" txt_f="16828">30</offsets></xref><offsets xml_i="25766" xml_f="25959" txt_i="16828" txt_f="17021">] who also found that, in subarachnoid route, sensory and motor blocks were significantly prolonged in nalbuphine-treated group while compared with control. However, on the contrary, Mukherjee </offsets><italic><offsets xml_i="25967" xml_f="25972" txt_i="17021" txt_f="17026">et al</offsets></italic><offsets xml_i="25981" xml_f="25983" txt_i="17026" txt_f="17028">.[</offsets><xref rid="ref29" ref-type="bibr"><offsets xml_i="26017" xml_f="26019" txt_i="17028" txt_f="17030">29</offsets></xref><offsets xml_i="26026" xml_f="26185" txt_i="17030" txt_f="17189">] found that though sensory block was significantly prolonged along with increasing concentration of nalbuphine, motor was quite comparable between two groups.</offsets></p><p><offsets xml_i="26192" xml_f="26357" txt_i="17190" txt_f="17355">In our study, duration of analgesia was 531.45 min and 501.02 min in nalbuphine and control groups, respectively. Thus, the duration of analgesia was significantly (</offsets><italic><offsets xml_i="26365" xml_f="26366" txt_i="17355" txt_f="17356">P</offsets></italic><offsets xml_i="26375" xml_f="26444" txt_i="17356" txt_f="17422"> &lt; 0.05) prolonged in nalbuphine-treated group. However, Chatrath </offsets><italic><offsets xml_i="26452" xml_f="26457" txt_i="17422" txt_f="17427">et al</offsets></italic><offsets xml_i="26466" xml_f="26468" txt_i="17427" txt_f="17429">.[</offsets><xref rid="ref28" ref-type="bibr"><offsets xml_i="26502" xml_f="26504" txt_i="17429" txt_f="17431">28</offsets></xref><offsets xml_i="26511" xml_f="26728" txt_i="17431" txt_f="17648">] found that epidurally administered nalbuphine does not prolong the duration of analgesia in a statistically significant manner while compared with the equipotent dose of tramadol in the same route. Again, Mukherjee </offsets><italic><offsets xml_i="26736" xml_f="26741" txt_i="17648" txt_f="17653">et al</offsets></italic><offsets xml_i="26750" xml_f="26752" txt_i="17653" txt_f="17655">.[</offsets><xref rid="ref29" ref-type="bibr"><offsets xml_i="26786" xml_f="26788" txt_i="17655" txt_f="17657">29</offsets></xref><offsets xml_i="26795" xml_f="26992" txt_i="17657" txt_f="17854">] found that duration of analgesia in subarachnoid block increases proportionally with the increase in the dose of nalbuphine applied intrathecally and the difference was statistically significant.</offsets></p><p><offsets xml_i="26999" xml_f="27173" txt_i="17855" txt_f="18029">In our study, patients of LN Group required significantly less number of diclofenac sodium injection in first 24 h of the postoperative period than the patients of LC Group (</offsets><italic><offsets xml_i="27181" xml_f="27182" txt_i="18029" txt_f="18030">P</offsets></italic><offsets xml_i="27191" xml_f="27214" txt_i="18030" txt_f="18050"> &lt; 0.05). Mukherjee </offsets><italic><offsets xml_i="27222" xml_f="27227" txt_i="18050" txt_f="18055">et al</offsets></italic><offsets xml_i="27236" xml_f="27238" txt_i="18055" txt_f="18057">.[</offsets><xref rid="ref29" ref-type="bibr"><offsets xml_i="27272" xml_f="27274" txt_i="18057" txt_f="18059">29</offsets></xref><offsets xml_i="27281" xml_f="27456" txt_i="18059" txt_f="18234">] also found in their study that rescue analgesic requirement in the form of IM diclofenac sodium is gradually lesser with increasing dose of nalbuphine applied intrathecally.</offsets></p><p><offsets xml_i="27463" xml_f="27618" txt_i="18235" txt_f="18390">In our study, we have found nausea, vomiting, sedation, and pruritus between both study groups, but the incidence was quite comparable between two groups (</offsets><italic><offsets xml_i="27626" xml_f="27627" txt_i="18390" txt_f="18391">P</offsets></italic><offsets xml_i="27636" xml_f="28102" txt_i="18391" txt_f="18854"> &gt; 0.05). For nausea, our patients needed no active management except increasing the fluid transfusion rate. Two patients in LN Group and one patient in LC Group suffered from vomiting. All the three patients managed with slow intravenous metoclopramide 10 mg. Sedation though was higher in nalbuphine group, it was quite arousable and did not cause any respiratory depression. Similarly, pruritus was higher in nalbuphine group, but it was self-limiting. Jyothi </offsets><italic><offsets xml_i="28110" xml_f="28115" txt_i="18854" txt_f="18859">et al</offsets></italic><offsets xml_i="28124" xml_f="28127" txt_i="18859" txt_f="18862">.,[</offsets><xref rid="ref31" ref-type="bibr"><offsets xml_i="28161" xml_f="28163" txt_i="18862" txt_f="18864">31</offsets></xref><offsets xml_i="28170" xml_f="28518" txt_i="18864" txt_f="19212">] in their study, with three different doses of nalbuphine (0.8, 1.6, and 2.5 mg intrathecally) found complications such as nausea, vomiting, urinary retention, shivering, pruritus, hypotension, and respiratory depression. Shivering, urinary retention, and hypotension were probably due to spinal anesthesia-related complications. Again, Ahluwalia </offsets><italic><offsets xml_i="28526" xml_f="28531" txt_i="19212" txt_f="19217">et al</offsets></italic><offsets xml_i="28540" xml_f="28542" txt_i="19217" txt_f="19219">.[</offsets><xref rid="ref30" ref-type="bibr"><offsets xml_i="28576" xml_f="28578" txt_i="19219" txt_f="19221">30</offsets></xref><offsets xml_i="28585" xml_f="28740" txt_i="19221" txt_f="19376">] found that only nausea and vomiting (5 vs. 2) was associated with intrathecal nalbuphine group while compared with tramadol in the same route. Mukherjee </offsets><italic><offsets xml_i="28748" xml_f="28753" txt_i="19376" txt_f="19381">et al</offsets></italic><offsets xml_i="28762" xml_f="28764" txt_i="19381" txt_f="19383">.[</offsets><xref rid="ref29" ref-type="bibr"><offsets xml_i="28798" xml_f="28800" txt_i="19383" txt_f="19385">29</offsets></xref><offsets xml_i="28807" xml_f="29163" txt_i="19385" txt_f="19741">] administered nalbuphine intrathecally (placebo, 0.2, 0.4, and 0.8 mg) for orthopedic surgery and found that few side effects such as pruritus, nausea vomiting, respiratory depression, and bradycardia were exclusively associated with the highest dose of nalbuphine and hypotension was evident in all the groups which was probably due to spinal anesthesia.</offsets></p><p><offsets xml_i="29170" xml_f="29241" txt_i="19742" txt_f="19813">Levobupivacaine dose was chosen as per recommendation in the textbook.[</offsets><xref rid="ref32" ref-type="bibr"><offsets xml_i="29275" xml_f="29277" txt_i="19813" txt_f="19815">32</offsets></xref><offsets xml_i="29284" xml_f="29355" txt_i="19815" txt_f="19886">] We had also followed the drug dose used by our previous researchers.[</offsets><xref rid="ref33" ref-type="bibr"><offsets xml_i="29389" xml_f="29391" txt_i="19886" txt_f="19888">33</offsets></xref><offsets xml_i="29398" xml_f="29477" txt_i="19888" txt_f="19967">] Even we had taken slightly lesser amount of drug to be on a safer side. Ambi </offsets><italic><offsets xml_i="29485" xml_f="29490" txt_i="19967" txt_f="19972">et al</offsets></italic><offsets xml_i="29499" xml_f="29501" txt_i="19972" txt_f="19974">.[</offsets><xref rid="ref33" ref-type="bibr"><offsets xml_i="29535" xml_f="29537" txt_i="19974" txt_f="19976">33</offsets></xref><offsets xml_i="29544" xml_f="29730" txt_i="19976" txt_f="20162">] had taken 36 ml of 0.5% levobupivacaine for perivascular and perineural ultrasound-guided axillary brachial plexus block and here we have taken 30 ml of 0.5% levobupivacaine. Chatrath </offsets><italic><offsets xml_i="29738" xml_f="29743" txt_i="20162" txt_f="20167">et al</offsets></italic><offsets xml_i="29752" xml_f="29755" txt_i="20167" txt_f="20170">.,[</offsets><xref rid="ref28" ref-type="bibr"><offsets xml_i="29789" xml_f="29791" txt_i="20170" txt_f="20172">28</offsets></xref><offsets xml_i="29798" xml_f="30237" txt_i="20172" txt_f="20611">] in their studies, used 10 mg nalbuphine in the lumbar epidural route safely without any appreciable complication. Again, the blood concentration of anesthetic drugs after various routes of administration reveals that drug concentration is the highest after intercostal nerve blockade, followed in order of decreasing concentration by injection into caudal epidural space, lumbar epidural space, brachial plexus, and subcutaneous tissue.[</offsets><xref rid="ref32" ref-type="bibr"><offsets xml_i="30271" xml_f="30273" txt_i="20611" txt_f="20613">32</offsets></xref><offsets xml_i="30280" xml_f="30693" txt_i="20613" txt_f="21026">] Thus, any drug used in brachial plexus blockade is associated with a lower risk of absorption and side effects than administered epidurally. Hence, we had chosen 10 mg nalbuphine for the use in brachial plexus block. While writing this discussion, we have found the reference of much higher dose (20 mg) of nalbuphine used for brachial plexus block for the patients undergoing elective forearm and hand surgery.</offsets></p><p><offsets xml_i="30700" xml_f="31097" txt_i="21027" txt_f="21424">Several hypothesized mechanisms of action have been suggested to explain the analgesic effect of nalbuphine. Nalbuphine is a synthetic mixed κ-agonist-µ-antagonist opioid with a moderate analgesic effect when compared to morphine. Apart from µ-opioid-based spinal and supraspinal analgesia, inhibition of neuronal serotonin uptake leads to augmentation of the spinal inhibitory pathways for pain.[</offsets><xref rid="ref34" ref-type="bibr"><offsets xml_i="31131" xml_f="31133" txt_i="21424" txt_f="21426">34</offsets></xref><offsets xml_i="31140" xml_f="31480" txt_i="21426" txt_f="21766">] Stimulation of opiate receptors on neurons of the central nervous system leads to an inhibition of intracellular adenylyl cyclase, an opening of potassium channels, and closing the calcium channels. This leads to hyperpolarization of the cell membrane potential and inhibition of action potential transmission of ascending pain pathways.[</offsets><xref rid="ref35" ref-type="bibr"><offsets xml_i="31514" xml_f="31516" txt_i="21766" txt_f="21768">35</offsets></xref><offsets xml_i="31523" xml_f="31524" txt_i="21768" txt_f="21769">]</offsets></p><p><offsets xml_i="31531" xml_f="31965" txt_i="21770" txt_f="22204">However, the great drawback of our study was that we had not taken any standardized dose of nalbuphine due to nonavailability of proper pharmaceutical reference relating to dose equivalence with other well-known opioids. A control group was included in our study, but it was little unethical to withhold any adjuvant in these patients for prolongation of postoperative analgesia, particularly when being posted for ambulatory surgery.</offsets></p><p><offsets xml_i="31972" xml_f="32386" txt_i="22205" txt_f="22619">Finally, we do conclude that, during day care forearm and hand surgery, addition of 10 mg nalbuphine hydrochloride to levobupivacaine 0.50% solution in supraclavicular brachial plexus block prolongs the duration of sensory and motor blockades, reduces the requirement of rescue analgesic in postoperative period but does not hasten the onset time of sensory and motor blockades without any appreciable side effect.</offsets></p><sec id="sec2-3"><title><offsets xml_i="32414" xml_f="32447" txt_i="22620" txt_f="22653">Financial support and sponsorship</offsets></title><p><offsets xml_i="32458" xml_f="32462" txt_i="22654" txt_f="22658">Nil.</offsets></p></sec><sec id="sec2-4" sec-type="COI-statement"><title><offsets xml_i="32521" xml_f="32542" txt_i="22660" txt_f="22681">Conflicts of interest</offsets></title><p><offsets xml_i="32553" xml_f="32588" txt_i="22682" txt_f="22717">There are no conflicts of interest.</offsets></p></sec></sec></body><back><ref-list><title>R<sc>EFERENCES</sc></title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGrath</surname><given-names>B</given-names></name><name><surname>Elgendy</surname><given-names>H</given-names></name><name><surname>Chung</surname><given-names>F</given-names></name><name><surname>Kamming</surname><given-names>D</given-names></name><name><surname>Curti</surname><given-names>B</given-names></name><name><surname>King</surname><given-names>S</given-names></name></person-group><article-title>Thirty percent of patients have moderate to severe pain 24 hr after ambulatory surgery: A survey of 5,703 patients</article-title><source>Can J Anaesth</source><year>2004</year><volume>51</volume><fpage>886</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">15525613</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fortier</surname><given-names>J</given-names></name><name><surname>Chung</surname><given-names>F</given-names></name><name><surname>Su</surname><given-names>J</given-names></name></person-group><article-title>Predictive factors of unanticipated admission in ambulatory surgery: A prospective study</article-title><source>Anesthesiology</source><year>1996</year><volume>85</volume><fpage>A27</fpage></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruce</surname><given-names>BG</given-names></name><name><surname>Green</surname><given-names>A</given-names></name><name><surname>Blaine</surname><given-names>TA</given-names></name><name><surname>Wesner</surname><given-names>LV</given-names></name></person-group><article-title>Brachial plexus blocks for upper extremity orthopaedic surgery</article-title><source>J Am Acad Orthop Surg</source><year>2012</year><volume>20</volume><fpage>38</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">22207517</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>RH</given-names></name><name><surname>Markham</surname><given-names>A</given-names></name></person-group><article-title>Levobupivacaine: A review of its pharmacology and use as a local anaesthetic</article-title><source>Drugs</source><year>2000</year><volume>59</volume><fpage>551</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">10776835</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crews</surname><given-names>JC</given-names></name><name><surname>Foreman</surname><given-names>AS</given-names></name><name><surname>Weller</surname><given-names>RS</given-names></name><name><surname>Moss</surname><given-names>JR</given-names></name><name><surname>Tucker</surname><given-names>SP</given-names></name></person-group><article-title>Onset, duration, and dose tolerability of levobupivacaine 0.5% for axillary brachial plexus neural blockade</article-title><source>Anesthesiology</source><year>1998</year><volume>89</volume><fpage>A894</fpage></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>CR</given-names></name><name><surname>Checketts</surname><given-names>MR</given-names></name><name><surname>Mackenzie</surname><given-names>N</given-names></name><name><surname>Scott</surname><given-names>NB</given-names></name><name><surname>Bannister</surname><given-names>J</given-names></name></person-group><article-title>Comparison of S(-)-bupivacaine with racemic (RS)-bupivacaine in supraclavicular brachial plexus block</article-title><source>Br J Anaesth</source><year>1998</year><volume>80</volume><fpage>594</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">9691860</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bazin</surname><given-names>JE</given-names></name><name><surname>Massoni</surname><given-names>C</given-names></name><name><surname>Groslier</surname><given-names>D</given-names></name><name><surname>Fenies</surname><given-names>V</given-names></name><name><surname>Bittar</surname><given-names>M</given-names></name><name><surname>Schoeffler</surname><given-names>P</given-names></name></person-group><article-title>Brachial plexus block: Effect of the addition of sufentanil to local anesthetic mixture on postoperative analgesia duration</article-title><source>Ann Fr Anesth Reanim</source><year>1997</year><volume>16</volume><fpage>9</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">9686089</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohli</surname><given-names>S</given-names></name><name><surname>Kaur</surname><given-names>M</given-names></name><name><surname>Sahoo</surname><given-names>S</given-names></name><name><surname>Vajifdar</surname><given-names>H</given-names></name><name><surname>Kohli</surname><given-names>P</given-names></name></person-group><article-title>Brachial plexus block: Comparison of two different doses of clonidine added to bupivacaine</article-title><source>J Anaesthesiol Clin Pharmacol</source><year>2013</year><volume>29</volume><fpage>491</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">24249986</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yadav</surname><given-names>RK</given-names></name><name><surname>Sah</surname><given-names>BP</given-names></name><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>Singh</surname><given-names>SN</given-names></name></person-group><article-title>Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: A prospective, randomized, double blinded, controlled study</article-title><source>Kathmandu Univ Med J (KUMJ)</source><year>2008</year><volume>6</volume><fpage>302</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">20071811</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jarbo</surname><given-names>K</given-names></name><name><surname>Batra</surname><given-names>YK</given-names></name><name><surname>Panda</surname><given-names>NB</given-names></name></person-group><article-title>Brachial plexus block with midazolam and bupivacaine improves analgesia</article-title><source>Can J Anaesth</source><year>2005</year><volume>52</volume><fpage>822</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16189333</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dogru</surname><given-names>K</given-names></name><name><surname>Yildirim</surname><given-names>D</given-names></name><name><surname>Ulgey</surname><given-names>A</given-names></name><name><surname>Aksu</surname><given-names>R</given-names></name><name><surname>Bicer</surname><given-names>C</given-names></name><name><surname>Boyaci</surname><given-names>A</given-names></name></person-group><article-title>Adding magnesium to levobupivacaine for axillary brachial plexus block in arteriovenous fistule surgery</article-title><source>Bratisl Lek Listy</source><year>2012</year><volume>113</volume><fpage>607</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">23094900</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pick</surname><given-names>CG</given-names></name><name><surname>Paul</surname><given-names>D</given-names></name><name><surname>Pasternak</surname><given-names>GW</given-names></name></person-group><article-title>Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice</article-title><source>J Pharmacol Exp Ther</source><year>1992</year><volume>262</volume><fpage>1044</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">1326621</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klepper</surname><given-names>ID</given-names></name><name><surname>Rosen</surname><given-names>M</given-names></name><name><surname>Vickers</surname><given-names>MD</given-names></name><name><surname>Mapleson</surname><given-names>WW</given-names></name></person-group><article-title>Respiratory function following nalbuphine and morphine in anaesthetized man</article-title><source>Br J Anaesth</source><year>1986</year><volume>58</volume><fpage>625</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">3707800</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunion</surname><given-names>MW</given-names></name><name><surname>Marchionne</surname><given-names>AM</given-names></name><name><surname>Anderson</surname><given-names>TM</given-names></name></person-group><article-title>Use of the mixed agonist-antagonist nalbuphine in opiod based analgesia</article-title><source>Acute Pain</source><year>2004</year><volume>6</volume><fpage>29</fpage><lpage>39</lpage></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lake</surname><given-names>CL</given-names></name><name><surname>Duckworth</surname><given-names>EN</given-names></name><name><surname>DiFazio</surname><given-names>CA</given-names></name><name><surname>Magruder</surname><given-names>MR</given-names></name></person-group><article-title>Cardiorespiratory effects of nalbuphine and morphine premedication in adult cardiac surgical patients</article-title><source>Acta Anaesthesiol Scand</source><year>1984</year><volume>28</volume><fpage>305</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">6430010</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tourtier</surname><given-names>JP</given-names></name><name><surname>Raynaud</surname><given-names>L</given-names></name><name><surname>Murat</surname><given-names>I</given-names></name><name><surname>Gall</surname><given-names>O</given-names></name></person-group><article-title>Audit of protocols for treatment of paediatric burns in emergency departments in the Île de France</article-title><source>Burns</source><year>2010</year><volume>36</volume><fpage>1196</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">20692768</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>RI</given-names></name><name><surname>Edwards</surname><given-names>WT</given-names></name><name><surname>Kezer</surname><given-names>EA</given-names></name><name><surname>Ferrari</surname><given-names>DA</given-names></name><name><surname>Liland</surname><given-names>AE</given-names></name><name><surname>Smith</surname><given-names>ER</given-names></name></person-group><article-title>Serial intravenous doses of dezocine, morphine, and nalbuphine in the management of postoperative pain for outpatients</article-title><source>Anesth Analg</source><year>1993</year><volume>77</volume><fpage>533</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8368552</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bone</surname><given-names>ME</given-names></name><name><surname>Dowson</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>G</given-names></name></person-group><article-title>A comparison of nalbuphine with fentanyl for postoperative pain relief following termination of pregnancy under day care anaesthesia</article-title><source>Anaesthesia</source><year>1988</year><volume>43</volume><fpage>194</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">3364636</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boothe</surname><given-names>P</given-names></name><name><surname>Finegan</surname><given-names>BA</given-names></name></person-group><article-title>Changing the admission process for elective surgery: An economic analysis</article-title><source>Can J Anaesth</source><year>1995</year><volume>42</volume><issue>5 Pt 1</issue><fpage>391</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">7614645</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavlin</surname><given-names>DJ</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Penaloza</surname><given-names>DA</given-names></name><name><surname>Polissar</surname><given-names>NL</given-names></name><name><surname>Buckley</surname><given-names>FP</given-names></name></person-group><article-title>Pain as a factor complicating recovery and discharge after ambulatory surgery</article-title><source>Anesth Analg</source><year>2002</year><volume>95</volume><fpage>627</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">12198050</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beauregard</surname><given-names>L</given-names></name><name><surname>Pomp</surname><given-names>A</given-names></name><name><surname>Choinière</surname><given-names>M</given-names></name></person-group><article-title>Severity and impact of pain after day-surgery</article-title><source>Can J Anaesth</source><year>1998</year><volume>45</volume><fpage>304</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">9597202</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>SM</given-names></name><name><surname>Nielsen</surname><given-names>KC</given-names></name></person-group><article-title>Brachial plexus blocks: Infusions and other mechanisms to provide prolonged analgesia</article-title><source>Curr Opin Anaesthesiol</source><year>2003</year><volume>16</volume><fpage>393</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17021488</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Axelsson</surname><given-names>K</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name></person-group><article-title>Local anaesthetic adjuvants: Neuraxial versus peripheral nerve block</article-title><source>Curr Opin Anaesthesiol</source><year>2009</year><volume>22</volume><fpage>649</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">19593120</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machata</surname><given-names>AM</given-names></name><name><surname>Willschke</surname><given-names>H</given-names></name><name><surname>Kabon</surname><given-names>B</given-names></name><name><surname>Kettner</surname><given-names>SC</given-names></name><name><surname>Marhofer</surname><given-names>P</given-names></name></person-group><article-title>Propofol-based sedation regimen for infants and children undergoing ambulatory magnetic resonance imaging</article-title><source>Br J Anaesth</source><year>2008</year><volume>101</volume><fpage>239</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">18534971</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amin</surname><given-names>SM</given-names></name><name><surname>Amr</surname><given-names>YM</given-names></name><name><surname>Fathy</surname><given-names>SM</given-names></name><name><surname>Alzeftawy</surname><given-names>AE</given-names></name></person-group><article-title>Maternal and neonatal effects of nalbuphine given immediately before induction of general anesthesia for elective cesarean section</article-title><source>Saudi J Anaesth</source><year>2011</year><volume>5</volume><fpage>371</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">22144923</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolan</surname><given-names>EA</given-names></name><name><surname>Murray</surname><given-names>WJ</given-names></name><name><surname>Immediata</surname><given-names>AR</given-names></name><name><surname>Gleason</surname><given-names>N</given-names></name></person-group><article-title>Comparison of nalbuphine and fentanyl in combination with diazepam for outpatient oral surgery</article-title><source>J Oral Maxillofac Surg</source><year>1988</year><volume>46</volume><fpage>471</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">3164051</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiwari</surname><given-names>AK</given-names></name><name><surname>Tomar</surname><given-names>GS</given-names></name><name><surname>Agrawal</surname><given-names>J</given-names></name></person-group><article-title>Intrathecal bupivacaine in comparison with a combination of nalbuphine and bupivacaine for subarachnoid block: A randomized prospective double-blind clinical study</article-title><source>Am J Ther</source><year>2013</year><volume>20</volume><fpage>592</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">21904194</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chatrath</surname><given-names>V</given-names></name><name><surname>Attri</surname><given-names>JP</given-names></name><name><surname>Bala</surname><given-names>A</given-names></name><name><surname>Khetarpal</surname><given-names>R</given-names></name><name><surname>Ahuja</surname><given-names>D</given-names></name><name><surname>Kaur</surname><given-names>S</given-names></name></person-group><article-title>Epidural nalbuphine for postoperative analgesia in orthopedic surgery</article-title><source>Anesth Essays Res</source><year>2015</year><volume>9</volume><fpage>326</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">26712968</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname><given-names>A</given-names></name><name><surname>Pal</surname><given-names>A</given-names></name><name><surname>Agrawal</surname><given-names>J</given-names></name><name><surname>Mehrotra</surname><given-names>A</given-names></name><name><surname>Dawar</surname><given-names>N</given-names></name></person-group><article-title>Intrathecal nalbuphine as an adjuvant to subarachnoid block: What is the most effective dose?</article-title><source>Anesth Essays Res</source><year>2011</year><volume>5</volume><fpage>171</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">25885383</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahluwalia</surname><given-names>P</given-names></name><name><surname>Ahluwalia</surname><given-names>A</given-names></name><name><surname>Varshney</surname><given-names>R</given-names></name><name><surname>Thakur</surname><given-names>S</given-names></name><name><surname>Bhandari</surname><given-names>S</given-names></name></person-group><article-title>A prospective randomized double blind study to evaluate the effects of intrathecal nalbuphine in patients of lower abdominal surgeries under spinal anaesthesia</article-title><source>Int J Sci Stud</source><year>2015</year><volume>3</volume><fpage>19</fpage><lpage>23</lpage></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jyothi</surname><given-names>B</given-names></name><name><surname>Shruthi</surname><given-names>G</given-names></name><name><surname>Shaikh</surname><given-names>SI</given-names></name></person-group><article-title>A comparison of analgesic effect of different doses of intrathecal nalbuphine hydrochloride with bupivacaine and bupivacaine alone for lower abdominal and orthopedic surgeries</article-title><source>Indian J Pain</source><year>2014</year><volume>28</volume><fpage>18</fpage><lpage>23</lpage></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Berde</surname><given-names>CB</given-names></name><name><surname>Strichartz</surname><given-names>GR</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Miller</surname><given-names>RD</given-names></name><name><surname>Cohen</surname><given-names>NH</given-names></name><name><surname>Eriksson</surname><given-names>LI</given-names></name><name><surname>Fleisher</surname><given-names>LA</given-names></name><name><surname>Wiener-Kronish</surname><given-names>JP</given-names></name><name><surname>Young</surname><given-names>WL</given-names></name></person-group><article-title>Local anesthetics</article-title><source>Miller's Anesthesia</source><year>2010</year><edition>8th ed</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>Elsevier Saunders</publisher-name><fpage>1028</fpage><lpage>55</lpage></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambi</surname><given-names>U</given-names></name><name><surname>Bhanupriya</surname><given-names>P</given-names></name><name><surname>Hulkund</surname><given-names>SY</given-names></name><name><surname>Prakashappa</surname><given-names>DS</given-names></name></person-group><article-title>Comparison between perivascular and perineural ultrasound-guided axillary brachial plexus block using levobupivacaine: A prospective, randomised clinical study</article-title><source>Indian J Anaesth</source><year>2015</year><volume>59</volume><fpage>658</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">26644614</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gear</surname><given-names>RW</given-names></name><name><surname>Miaskowski</surname><given-names>C</given-names></name><name><surname>Gordon</surname><given-names>NC</given-names></name><name><surname>Paul</surname><given-names>SM</given-names></name><name><surname>Heller</surname><given-names>PH</given-names></name><name><surname>Levine</surname><given-names>JD</given-names></name></person-group><article-title>The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain</article-title><source>Pain</source><year>1999</year><volume>83</volume><fpage>339</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">10534607</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acharya</surname><given-names>R</given-names></name><name><surname>Jena</surname><given-names>M</given-names></name><name><surname>Mishra</surname><given-names>S</given-names></name><name><surname>Rath</surname><given-names>SK</given-names></name></person-group><article-title>Effect of butorphanol versus placebo as adjuvant to bupivacaine for supraclavicular brachial plexus blockade</article-title><source>Int J Appl Pharm</source><year>2014</year><volume>6</volume><fpage>8</fpage><lpage>10</lpage></element-citation></ref></ref-list></back></article>